Literature DB >> 31185647

Bioactive Dimeric Abietanoid Peroxides from the Bark of Cryptomeria japonica.

Chi-I Chang1,2, Cheng-Chi Chen3, Chiy-Rong Chen4, Ming-Der Wu5, Ming-Jen Cheng6, Ping-Jyun Sung7,8, Yueh-Hsiung Kuo9,10,11.   

Abstract

Three new dimeric abietane-type diterpenoids, abieta-6,8,11,13-tetraen-12-yl 12-hydroxyabieta-8,11,13-trien-7α-yl peroxide (1), abieta-6,8,11,13-tetraen-12-yl 12-hydroxyabieta-8,11,13-trien-7β-yl peroxide (2), and 12-hydroxyabieta-8,11,13-trien-7β-yl 7-oxoabieta-5,8,11,13-tetraen-12-yl peroxide (3), together with four known abietane-type diterpenoids (4-7) were isolated from the methanol extract of the bark of Cryptomeria japonica. Their structures were elucidated on the basis of spectroscopic analysis and comparison of NMR data with those of known analogues. At a concentration of 50 μM, compounds 1, 2, and 3 showed 26.2%, 23.6%, and 35.7% inhibition towards xanthine oxidase enzyme, respectively. In addition, compound 3 also showed 24.9% inhibition toward angiotensin-converting enzyme (ACE).

Entities:  

Keywords:  Cryptomeria japonica; Cupressaceae; dimeric abietane; diterpenoid

Mesh:

Substances:

Year:  2019        PMID: 31185647      PMCID: PMC6600475          DOI: 10.3390/molecules24112178

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


1. Introduction

The Japanese cedar, Cryptomeria japonica D. Don (Cupressaceae), belongs to the monotypic genus in the Cupressaceae [1]. It is a massive evergreen coniferous tree, growing up to 50 m in height. Due to the aromatic, reddish-pink in color, soft, lightweight but strong, and waterproof properties of its wood, it is planted in large quantities and used as building materials and wood products. This plant has been cultivated as an important coniferous tree species in Taiwan since 1906. Phytochemical investigations indicated the presence of monoterpenoids, sesquiterpenoids, and diterpenoids [2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24] in the leaves, heartwood, and barks of C. japonica. The crude extracts and secondary metabolites from this species exhibited a wide array of bioactivities including cytotoxic [23], antifungal [24], antibacterial [23], antioxidant [25], anti-inflammatory [26], and insect antifeedant [27] and repellent [18] properties. While searching for bioactive chemical ingredients of the bark of C. japonica, we have already reported the isolation of three sesquarterpenoids [28,29] and ten abietane-type diterpenoids [30,31,32]. Herein, the isolation and structure elucidation of three new dimeric abietane-type diterpenoids are described as well as their inhibitory activity towards xanthine oxidase and angiotensin-converting enzymes.

2. Results and Discussion

2.1. Isolation and Structural Elucidation

The MeOH extract of the bark of C. japonica was suspended in H2O and then partitioned with EtOAc and n-BuOH, successively. The EtOAc-soluble portion was submitted to repeated silica gel column chromatography and semipreparative normal phase-HPLC to afford compounds 1–7 (Figure 1).
Figure 1

The chemical structures of compounds 1–7 isolated from C. japonica.

The high resolution electron impact mass spectrum (HR-EI-MS) of 1 gave a molecular ion at m/z 584.4238, corresponding to the molecular formula of C40H56O3, with thirteen degrees of unsaturation. The electron impact mass spectrum (EI-MS) of 1 displayed the fragmental ions at m/z 300 [C20H28O2]+ and 284 [C20H28O]+ (Figure 2) and forty carbon signals were observed in the 13C-NMR spectrum, indicating that 1 was a dimeric diterpenoid (Figure 2). The UV and IR spectra showed absorption bands for hydroxyl (3409 cm−1) and aromatic (λmax 220 and 279 nm; 3049, 1593, and 1487 cm−1) groups. The 1H- and 13C-NMR data of 1 (Table 1) showed one set of dehydroabietane diterpene signals for constituent upper monomer-1 including three tertiary methyl groups (δH 0.97, 0.98, and 1.36 (each 3H, s, Me-18, Me-19, and Me-20)), an isopropyl group attached to a phenyl group (δH 0.78 (3H, d, J = 7.0 Hz, Me-16), 1.01 (3H, d, J = 7.0 Hz, Me-17), and 2.85 (1H, sept, J = 7.0 Hz, H-15)), two para aromatic protons (δH 6.34 (1H, s, H-14) and 6.69 (1H, s, H-11)), a phenolic hydroxyl proton (δH 4.33 (1H, s, exchangeable with D2O)), and a typical downshifted Hβ-1 signal of a dehydroabietane diterpene (δH 1.96 (1H, br d, J = 12.0 Hz)) [33]. A downshifted benzyl proton connected with a peroxyl group (δH 5.86 (1H, br s, H-7)), instead of a hydroxyl group [19,33,34], was assigned as H-7, suggested by the 1H-1H COSY correlations with the two methylene protons of H-6 (δH 2.28 (1H, m), δH 2.32 (1H, m)), and HMBC correlations with C-5 (δC 43.5) and C-8 (δC 145.6; Figure 3). In addition, the 1H-NMR signal of H-7 was a broad singlet peak and showed the NOESY correlation with both Hα-6 (δH 2.32) and Hβ-6 (δH 2.28), hinted that the peroxyl group was attached on C-7 in α-axial orientation [33] (Figure 3). These data proved that the structure of constituent monomer-1 was related to 7α-peroxyferruginol. The 1H- and 13C-NMR data of 1 (Table 1) also exhibited another set of dehydroabietane diterpene signals for constituent lower monomer-2 including three tertiary methyl groups (δH 0.94, 1.04, and 1.11 (each 3H, s, Me-18′, Me-19′, and Me-20′)), an isopropyl group attached to a phenyl group (δH 0.81 (3H, d, J = 7.0 Hz, Me-16′), 0.98 (3H, d, J = 7.0 Hz, Me-17′), and 2.82 (1H, sept, J = 7.0 Hz, H-15′)), two para aromatic protons (δH 6.98 (1H, s, H-11′) and 6.77 (1H, s, H-14′)), an ABX coupling system of one methine proton (δH 2.07 (1H, dd, J = 3.0, 2.5 Hz, H-5′)), and two vinyl protons (δH 5.87 (1H, dd, J = 9.5, 2.5 Hz, H-6′) and 6.45 (1H, dd, J = 9.5, 3.0 Hz, H-7′)), together with a typical downshifted Hβ-1 signal of a dehydroabietane diterpene (δH 2.22 (1H, br d, J = 13.0 Hz)) [33]. The above NMR spectroscopic data suggested constituent lower monomer-2 was related to 6,7-dehydroferruginol [35]. Thus, the gross structure of 1 is composed of 7α-hydrperoxyferruginol and 6,7-dehydroferruginol. The chemical shift of H-7 appeared at the lower field region (δH 5.86) in constituent monomer-1, comparing to that of the 7α-hydroxyferruginol analogues [34] implied that the connectivity of two monomers between C-7 and C-12′ through a peroxide functionality. The NOESY correlation between H-7 and H-11′ (δH 6.98; Figure 3) further confirmed this proposal. Interestingly, there are some electrostatic attraction between the electron-rich aryl, the phenol functionality of upper 7α-peroxyferruginol derivative, and the electron-deficient aryl, with peroxide moiety of lower 6,7-dehydroferruginol, formed the most stable conformer as shown in Figure 3. Due to the anisotropic effect from the opposite phenyl group, H-14, H-15, H-16, H-17, H-14′, H-15′, H-16′, H-17′, and phenol of 1 were posited in the shielding region and thus showed the higher field chemical shifts than that of the usual dehydroabietane diterpene. In contrast, H-5, H-7, and H-20’ of 1 were located in the deshielding region and thus exhibit a lower field chemical shifts than that of the usual dehydroabietane diterpene [33]. Complete 1H- and 13C-NMR chemical shifts were established by 1H-1H COSY, HMQC, HMBC, and NOESY spectra. Based on these above evidences, compound 1 was elucidated as abieta-6,8,11,13-tetraen-12-yl 12-hydroxyabieta-8,11,13-trien-7α-yl peroxide.
Figure 2

Some key electron impact (EI)-Mass fragmentations of compounds 1 and 3.

Table 1

NMR (nuclear magnetic resonance) data (CDCl3) of compound 1–3. δ in ppm, J in Hz.

No.123
δC aδH bδCδHδCδH
141.41.78 m, 1.96 br d (12.0)40.81.80 m, 1.93 br d (12.0)41.01.78 m, 1.93 br d (12.1)
218.81.59 m18.61.60 m18.61.59 m, 1.77 m
342.81.30 td (13.0, 3.5), 1.50 m42.61.25 m, 1.51m42.41.25 m, 1.51 m
434.5 34.8 34.7
543.51.96 m47.61.59 m47.31.72 m
634.02.28 m, 2.32 m34.82.24 br d (14.0), 2.40 m34.22.24 br d (14.3), 2.41 m
797.05.86 br s104.15.20 d (8.0)102.75.38 dd (9.0, 2.5)
8145.6 147.2 146.0
9142.2 143.1 142.5
1040.6 40.7 41.5
11113.36.69 s113.56.74 s114.06.79 s
12148.4 148.9 149.5
13131.9 132.8 133.1
14121.36.34 s120.96.72 s120.76.68 s
1526.32.85 sept (7.0)27.33.01 sept (7.0)27.33.02 sept (7.0)
1622.30.78 d (7.0)22.61.18 d (7.0)22.51.16 d (7.0)
1722.21.01 d (7.0)21.71.16 d (7.0)21.71.11 d (7.0)
1833.50.97 s33.80.95 s33.70.97 s
1923.20.98 s23.11.02 s23.11.01 s
2021.91.36 s21.41.37 s21.71.36 s
12-OH 4.33 s 4.52 s 4.52
1′36.21.55 m, 2.22 br d (13.0)36.31.65 m, 2.13 m38.01.72 m, 2.51 br d (13.5)
2′19.01.75 m, 1.65 m18.81.69 m18.72.00 br d (13.5), 1.70 m
3′41.01.23 m, 1.51m40.91.23 m, 1.51m40.31.45 m, 1.70 m
4′32.8 32.8 37.5
5′51.12.07 dd (3.0, 2.5)51.12.13 dd (3.0, 2.0)173.2
6′127.65.87 dd (9.5, 2.5)128.05.90 dd (9.5,3.0)124.56.48 s
7′127.36.45 dd (9.5, 3.0)127.46.51 dd (9.5,2.0)185.4
8′126.5 127.3 124.5
9′146.6 146.9 153.5
10′38.1 37.9 41.4
11′107.76.98 s109.16.95 s109.67.19 s
12′152.9 153.6 158.2
13′133.6 135.4 136.9
14′124.46.77 s124.56.92 s124.58.03 s
15′27.02.82 sept (7.0)26.53.34 sept (7.0)26.93.32 sept (7.0)
16′21.90.81 d (7.0)22.91.21 d (7.0)22.61.23 d (7.0)
17′22.20.98 d (7.0)22.81.19 d (7.0)22.51.20 d (7.0)
18′32.60.94 s32.60.97 s32.60.97 s
19′22.51.04 s22.51.03 s29.01.03 s
20′20.51.11 s23.01.00 s32.31.49 s

Recorded at a 100 MHz (13C); and b 400 MHz (1H).

Figure 3

Significant HMBC (one-headed arrows) and NOESY (two-headed arrows) correlations of compounds 1–3.

Compound 2 was an isomer of 1 with the same molecular formula C40H56O3, determined by the molecular ion of HR-EI-MS at m/z 584.4237. Its EI-MS also showed the fragmental ions at m/z 300 [C20H28O2]+ and 284 [C20H28O]+, indicating that 2 was also a dimeric diterpenoid. The absorptions for hydroxyl (3423 cm−1) and aromatic (3048, 1590, and 1493 cm−1; λmax 217 and 276 nm) groups were also found in the UV and IR spectra. Comparison of 1H and 13C-NMR data of 2 and 1 (Table 1) showed that the signals of constituent lower monomer-2 of 2 were almost the same as those of 1, indicating the structure of constituent lower monomer-2 is related to 6,7-dehydroferruginol. The 1H- and 13C-NMR data of 2 (Table 1) also showed another set of dehydroabietane diterpene signals for constituent upper monomer-1 including three tertiary methyl groups (δH 0.95, 1.02, and 1.37 (each 3H, s, Me-18, Me-19, and Me-20)), an isopropyl group attached to a phenyl group (δH 1.16 (3H, d, J = 7.0 Hz, Me-17), 1.18 (3H, d, J = 7.0 Hz, Me-16), and 3.01 (1H, sept, J = 7.0 Hz, H-15)), two para aromatic protons (δH 6.72 (1H, s, H-14) and 6.74 (1H, s, H-11)), a phenolic hydroxyl proton (δH 4.52 (1H, s)), and a typical downshifted Hβ-1 signal of a dehydroabietane diterpene (δH 1.93 (1H, br d, J = 12.0 Hz)) [33]. A downshifted benzyl proton connected with a peroxyl group (δH 5.20 (1H, d, J = 8.0 Hz, H-7)) was assigned as H-7, suggesting by the 1H-1H COSY correlations with the two methylene protons of H-6 (δH 2.24 (1H, m, Hα-6), δH 2.40 (1H, br d, J = 8.0 Hz, Hβ-6)) and HMBC correlations with C-5 (δC 47.6) and C-8 (δC 147.2; Figure 3). Since the 1H-NMR signal of H-7 was a doublet peak with a constant coupling constant, 8.0 Hz, the peroxyl group on C-7 was in β-equational orientation (Figure 2), instead of in α-axial orientation in 1 [33]. H-7 showed the NOESY correlation with Hα-6 (δH 2.24) and 1.59 (H-5, m), but the lack of NOESY correlation with Hβ-6 (δH 2.40) further confirmed this proposal (Figure 3). Thus, the structure of 2 was identified as abieta-6,8,11,13-tetraen-12-yl 12-hydroxyabieta-8,11,13-trien-7β-yl peroxide. Compound 2 did not exhibit the most stable conformer as in 1. Therefore, the chemical shifts of two isopropyl groups in 2 were not shifted to the high field region. The HR-EI-MS of 3 showed a molecular ion at m/z 598.4018, which corresponded to the molecular formula, C40H54O4, indicating fourteen degrees of unsaturation. The EI-MS fragmental ions of 3 at m/z 300 [C20H28O2]+ and 298 [C20H26O3]+ indicated that 3 was also a dimeric diterpenoid. The absorptions for hydroxyl (3376 cm−1), benzoyl (1639 cm−1; λmax 233, 282, and 310 nm) and aromatic (3049, 1586, and 1467 cm−1) groups were also found in its UV and IR spectra. Comparison of 1H- and 13C-NMR data of 3 and 2 (Table 1) showed that the signals of constituent monomer-1 of 3 were almost the same as those of 2, indicating the structure of constituent upper monomer-1 is related to 7α-peroxyferruginol. The 1H- and 13C-NMR data of 3 (Table 1) also showed another set of dehydroabietane diterpene signals for constituent lower monomer-2 as follows: Three tertiary methyl groups (δH 0.97, 1.03, and 1.49 (each 3H, s, Me-18′, Me-19′, and Me-20)), an isopropyl group attached to a phenyl group (δH 1.20 (3H, d, J = 7.0 Hz, Me-17’), 1.23 (3H, d, J = 7.0 Hz, Me-16’) and 3.32 (1H, sept, J = 7.0 Hz, H-15′)), two para aromatic protons (δH 7.19 (1H, s, H-11′) and 8.03 (1H, s, H-14′)), one trisubstituted double bond (δH 6.48 (1H, s, H-6′); δC 124.5 (C-6′), 173.2 (C-5′)), and a typical downshifted Hβ-1 signal of a dehydroabietane diterpene (δH 2.51 (1H, br d, J = 13.5 Hz, H-1′)). The NMR spectroscopic data of constituent lower monomer-2 showed a close structural resemblance to that of 5,6-dehydrosugiol [36]. Thus, the structure of constituent lower monomer-2 was tentatively determined as 5,6-dehydrosugiol-related abietane. H-7 exhibited a doublet of a doublet signal with two coupling constants, 9.0 and 2.5 Hz and showed the NOESY correlation with Hα-6 (δH 2.24) and H-5 (δH 1.72), but the lack of NOESY correlation with Hβ-6 (δH 2.41), which confirmed the peroxyl group was attached on C-7 in β-equational orientation (Figure 2) [33]. Thus, the structure of 3 was identified as 12-hydroxyabieta-8,11,13-trien-7β-yl 7-oxoabieta-5,8,11,13-tetraen-12-yl peroxide. Four known compounds were identified by comparison of the NMR data with those described in the literatures as sugiol (4) [37], 16-hydroxysugiol (5) [38], 12-dehydroxy-15-hydroxysugiol (6) [39], and 12-O-acetylsugiol (7) [40].

2.2. Inhibitory Activities Toward Xanthine Oxidase and Angiotensin-Converting Enzyme

Xanthine oxidase is a key enzyme in purine metabolic pathway, catalyzing oxypurines (hypoxanthine and xanthine) to uric acid and plays an important role in causing gout [41]. Additionally, the angiotensin-converting enzyme (ACE) plays a key physiological role in blood pressure regulation of the renin–angiotensin system due to its action in the formation of angiotensin II, a potent vasoconstrictor, and in the degradation of bradykinin, a vasodilator [42]. Compounds 1–3 were evaluated using the above two enzyme inhibitory activities [43,44]. At the concentration of 50 μM, compounds 1–3 exhibited 26.2%, 23.6%, and 35.7% xanthine oxidase inhibitory activity, respectively. Compound 3 also showed 24.9% ACE inhibitory activity, while compounds 1 and 2 were inactive. Analysis of the relationship between structure and activity in compounds 1–3 showed that the inhibitory activities toward the two above enzymes of compound 3 containing a 5,6-dehydrosugiol moiety at C-7 were higher than that of compounds 1 and 2 with a 6,7-dehydroferruginol moiety at C-7. Furthermore, the different orientations of the 7-substituent between compounds 1 and 2 had no significant effect on their xanthine oxidase inhibitory activity.

3. Experimental Section

3.1. Chemicals

Xanthine, Xanthine oxidase, and ACE (EC 3.4.15.1) from rabbit lungs, hippuryl-l-histidyl-l-leucine (HHL), ferulic acid (FA), sodium chloride (NaCl), and sodium hydroxide (NaOH) were purchased from Sigma Chemical Co. (St. Louis, MO, USA). Other chemicals used in this experiment were analytical grade. The water was obtained from a Milli-Q® (Millipore) water purification system (Billerica, MA, USA).

3.2. General

Optical rotations were made on a JASCO DIP-180 digital polarimeter. UV and IR spectra were recorded on a Shimadzu UV-1601PC and a Perkin-Elmer 983 G spectrophotometer, respectively. 1H- and 13C-NMR spectra were acquired on a Varian-Unity-Plus-400 spectrometer with residual solvent signals as internal reference. Chemical shifts are given in δ values and coupling constants (J) are given in hertz (Hz). EI-MS and HR-EI-MS were measured with a Jeol-JMS-HX300 mass spectrometer. Column chromatography (CC) was performed with silica gel (230–400 mesh; Merck & Co., Inc., Kenilworth, NJ, USA). TLC was performed with pre-coated silica gel plates (60 F-254; Merck & Co., Inc., Kenilworth, NJ, USA). Semi-preparative HPLC was performed using a normal phase column (Purospher STAR Si, 5 mm, 250 × 10 mm; Merck & Co., Inc., Kenilworth, NJ, USA) on a LDC Analytical-III system.

3.3. Plant Material

The bark of C. japonica D. Don was collected in Sitou, Taiwan in June, 2000. The plant material was identified by Dr. Yen-Hsueh Tseng, Department of Forestry, National Chung-Hsing University (NCHU). A voucher specimen (TCF13443) was deposited at the Herbarium of the Department of Forestry, NCHU, Taiwan.

3.4. Extraction and Isolation

The air-dried bark of C. japonica (16.0 kg) was extracted by maceration with MeOH (100 L) three times (seven days each time) at room temperature. After filtration, the combined MeOH extract was evaporated under reduced pressure to give a crude extract (480 g). The obtained extract was suspended in H2O (1 L), and successively partitioned with EtOAc (1 L) and n-BuOH (1 L) three times. The EtOAc soluble fraction (430 g) was loaded onto a silica gel (4.0 kg) column and eluted with n-hexaneEtOAc and EtOAcMeOH mixtures to give 11 fractions, fr. 1 (2.6 g), 2 (29.4 g), 3 (47.8 g), 4 (92.4 g), 5 (21.6 g), 6 (18.1 g), 7 (22.5 g), 8 (35.8 g), 9 (19.2 g), 10 (44.2 g), and 11 (72.2 g). Fr. 3 from hexane/EtOAc (9:1) elution was further purified through a silica gel column (7 cm × 60 cm) and eluted with hexane/CH2Cl2 (1:0–0:1 v/v) to obtain nine fractions, 3A–3I. Further purification of subfraction 3E by HPLC gave 4 (15.1 mg) and 7 (1.5 mg) using hexane/EtOAc (9:1 v/v). Further purification of subfraction 3G by HPLC gave 3 (2.4 mg) using hexane/EtOAc (10:1 v/v). Further purification of subfraction 3H by HPLC gave 1 (1.6 mg) and 2 (3.3 mg) using hexane/EtOAc (9:1 v/v). Fr. 5 from n-hexaneEtOAc (7:3 v/v) elution was further purified over a silica gel column (5 cm × 45 cm), eluted with n-hexaneCH2Cl2EtOAc (8:8:1 to 0:1:1 v/v/v) to yield fifteen fractions, 5A–5O. Further purification of subfraction 5E by HPLC gave 5 (0.5 mg) and 6 (1.9 mg) using n-hexaneEtOAc (7:3 v/v). Abieta-6,8,11,13-tetraen-12-yl 12-hydroxyabieta-8,11,13-trien-7α-yl peroxide (1). Gum; [α: −21.2 (c = 0.7, CHCl3); EI-MS (70 eV) m/z (rel. int.): 584 ([M]+, 1), 300 (77), 284 (100), 269 (18), 227 (15), 213 (39), 202 (530), 189 (91); HR-EI-MS m/z: 584.4238 [M]+ (calculated for C40H56O3 584.4232); UV (MeOH) λmax (log ε): 220 (4.74), 279 (4.41) nm; IR (KBr) νmax: 3409, 3049, 1593, 1487, 1460, 1407, 1255, 1169, 1043, 1009, 890 cm−l; 1H-NMR and 13C-NMR (400/100 MHz, in CDCl3): See Table 1; chemical spectra is in the Supplementary Materials. Abieta-6,8,11,13-tetraen-12-yl 12-hydroxyabieta-8,11,13-trien-7β-yl peroxide (2). Gum; [α: −54.6 (c = 1.0, CHCl3); EI-MS (70 eV) m/z (rel. int.): 584 ([M]+, 1), 582 (3), 473 (7), 313 (5), 300 (45), 284 (100), 269 (9), 213 (15), 202 (30), 189 (25), 59 (14); HR-EI-MS: m/z: 584.4237 [M]+ (calculated for C40H56O3 584.4232); UV (MeOH) λmax (log ε): 217 (4.80), 276 (4.45) nm; IR (KBr) νmax 3423, 3048, 1590, 1493, 1460, 1407, 1261, 1169, 1062, 1036, 1003, 963, 890, 738 cm−1; 1H-NMR and 13C-NMR (400/100 MHz, in CDCl3): See Table 1; chemical spectra is in the Supplementary Materials. 12-Hydroxyabieta-8,11,13-trien-7β-yl 7-oxoabieta-5,8,11,13-tetraen-12-yl peroxide (3). Gum; [α: −39.7 (c = 0.8, CHCl3); EI-MS m/z 598 ([M]+, 1), 300 (50), 298 (26), 285 (63), 229 (47), 213 (41), 203 (37), 189 (100), 69 (37), 55 (44); HR-EI-MS m/z [M]+: 598.4018 [M]+ (calculated for C40H54O4 598.4024); UV (MeOH) λmax (log ε): 233 (4.34), 282 (4.08), 310 (3.88) nm; IR (KBr) νmax 3376, 3049, 1639, 1586, 1467, 1407, 1275, 1182, 1036, 990, 897 cm−1; 1H-NMR and 13C-NMR (400/100 MHz, in CDCl3): See Table 1; chemical spectra is in the Supplementary Materials.

3.5. Xanthine Oxidase Inhibition Assay

The inhibitory effect on xanthine oxidase of compounds 1–3 was measured spectrophotometrically according to the method reported by Chen et al. with minor modifications [43]. The mixture assay consisted of a 35 μL of 0.1 mM phosphate buffer (pH = 7.5), 30 μL of enzyme solution (0.01 units/mL in 0.1 mM phosphate buffer, pH = 7.5), and 20 μL of the sample solution (final concentration was 50 μM). The mixture was pre-incubated at 25 °C for 15 min, and then was initiated by adding 60 μL of substrate solution (150 mM xanthine in the same buffer). The reaction mixture was incubated for further 30 min at 25 °C. The reaction was stopped by adding 50 μL of 2 N HCl, and the absorbance was measured at 290 nm using a microplate reader. The percentage activity of xanthine oxidase was calculated as following the formula: XO Inhibition (%) = (1 − B/A) × 100, where A and B are the activities of the enzyme without and with test sample. Quercetin, a known inhibitor of xanthine oxidase, was used as a positive control, whereas a negative control was performed without any inhibitor.

3.6. Angiotensin-I Converting Enzyme (ACE) Inhibition Assay

ACE assay was performed using the modified spectrophotometric method described by Cushman and Cheung with minor modifications [44]. The assay mixture contained 30 µL 2.5 mM Hippuryl-l-histidyl-l-leucine (HHL), 10 µL of testing sample at a certain concentration, and 20 µL of ACE (0.05 mU/µL) in 200 mM borate buffer containing 300 mM NaCl (adjusted to pH 8.3). The mixture was incubated at 37 °C for 60 min, and then was halted by addition of 30 μL of 2 N HCl. The substrate HHL and product hippuric acid (HA) liberated through hydrolysis of HHL were determined by HPLC equipped with a Hypersil GOLD C-18 analytical column (250 mm × 4.6 mm, 5 μm). The column was eluted with a mobile phase of 23% ACN containing 0.1% TFA at a constant flow rate of 1 mL/min for 15 min and monitored for absorbance at 228 nm. The inhibition activity was calculated using the following formula: ACE Inhibition (%) = [1 − (∆AInhibitor/∆ABlank)] × 100, where ∆AInhibitor and ∆ABlank were the peak areas of HA in testing and blank samples, respectively. Captopril, a known inhibitor of ACE, was used as a positive control, whereas a negative control was performed without any inhibitor.

4. Conclusions

In this study, three new dimeric abietanoid peroxides, abieta-6,8,11,13-tetraen-12-yl 12-hydroxyabieta-8,11,13-trien-7α-yl peroxide (1), abieta-6,8,11,13-tetraen-12-yl 12-hydroxyabieta-8,11,13-trien-7β-yl peroxide (2), and 12-hydroxyabieta-8,11,13-trien-7β-yl 7-oxoabieta-5,8,11,13-tetraen-12-yl peroxide (3), together with four known abietane-type diterpenoids (4–7) were isolated and characterized from the bark of C. japonica. At a concentration of 50 μM, the three new compounds exhibited the xanthine oxidase inhibitory activity. In addition, compounds 3 also showed ACE inhibitory activity.
  19 in total

Review 1.  Angiotensin-converting enzyme and the regulation of vasoactive peptides.

Authors:  R L Soffer
Journal:  Annu Rev Biochem       Date:  1976       Impact factor: 23.643

2.  Antifeedants against Acusta despesta from the Japanese cedar, Cryptomeria japonica II.

Authors:  X H Chen; C S Kim; T Kashiwagi; S Tebayashi; M Horiike
Journal:  Biosci Biotechnol Biochem       Date:  2001-06       Impact factor: 2.043

3.  Three abietane diterpenes and two diterpenes incorporated sesquiterpenes from the bark of Cryptomeria japonica.

Authors:  Kazuko Yoshikawa; Toshinori Tanaka; Akemi Umeyama; Shigenobu Arihara
Journal:  Chem Pharm Bull (Tokyo)       Date:  2006-03       Impact factor: 1.645

4.  A diterpene quinone from the bark of Cryptomeria japonica.

Authors:  Hisayoshi Kofujita; Michikazu Ota; Kouetsu Takahashi; Yasushi Kawai; Yoshiki Hayashi
Journal:  Phytochemistry       Date:  2002-12       Impact factor: 4.072

5.  Abietane diterpenoids from the barks of Cryptomeria japonica.

Authors:  Kazuko Yoshikawa; Kentaro Suzuki; Akemi Umeyama; Shigenobu Arihara
Journal:  Chem Pharm Bull (Tokyo)       Date:  2006-04       Impact factor: 1.645

6.  A new abietane and two dimeric abietane diterpenes from the black heartwood of Cryptomeria japonica.

Authors:  Shigenobu Arihara; Akemi Umeyama; Shinya Bando; Shinji Imoto; Mikako Ono; Mayo Tani; Kazuko Yoshikawa
Journal:  Chem Pharm Bull (Tokyo)       Date:  2004-03       Impact factor: 1.645

7.  Hepatoprotective phytocompounds from Cryptomeria japonica are potent modulators of inflammatory mediators.

Authors:  Lie-Fen Shyur; Chi-Chang Huang; Chiu-Ping Lo; Chih-Yang Chiu; Yi-Ping Chen; Sheng-Yang Wang; Shang-Tzen Chang
Journal:  Phytochemistry       Date:  2008-03-06       Impact factor: 4.072

8.  Repellents in the Japanese cedar, Cryptomeria japonica, against the pill-bug, Armadillidium vulgare.

Authors:  Jun Morisawa; Chul-Sa Kim; Takehiro Kashiwagi; Shin-ichi Tebayashi; Michio Horiike
Journal:  Biosci Biotechnol Biochem       Date:  2002-11       Impact factor: 2.043

9.  Antifeedants against Locusta migratoria from the Japanese Cedar, Cryptomeria japonica II.

Authors:  Bin Wu; Takehiro Kashiwagi; Ikuhiro Kuroda; Xiao Hui Chen; Shin-ich Tebayashi; Chul-Sa Kim
Journal:  Biosci Biotechnol Biochem       Date:  2008-02-07       Impact factor: 2.043

10.  Antioxidant activity of some plant extracts towards xanthine oxidase, lipoxygenase and tyrosinase.

Authors:  Chin-Hui Chen; Hsiu-Chen Chan; Yi-Tsu Chu; Hsin-Yi Ho; Pi-Yu Chen; Tzong-Huei Lee; Ching-Kuo Lee
Journal:  Molecules       Date:  2009-08-10       Impact factor: 4.411

View more
  1 in total

1.  Terpenoids of the Swamp Cypress Subfamily (Taxodioideae), Cupressaceae, an Overview by GC-MS.

Authors:  Bernd R T Simoneit; Angelika Otto; Daniel R Oros; Norihisa Kusumoto
Journal:  Molecules       Date:  2019-08-21       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.